Shizukanolide H is primarily studied for its potential anti-inflammatory and anticancer properties. It has shown inhibitory effects on certain tumor cell lines, making it a compound of interest in oncology research. Its ability to modulate cellular signaling pathways, particularly those involved in inflammation and cell proliferation, suggests possible use in developing targeted therapies for cancer and chronic inflammatory diseases. Due to its natural origin and structural complexity, it also serves as a lead compound in the synthesis of novel bioactive derivatives. Research remains in the preclinical stage, focusing on mechanism of action and efficacy in cellular and animal models.